Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Royston L, Masouridi-Levrat S, Gotta V, Royston E, Pressacco-Brossier C, Abi Aad Y, Tonoli D, Karmime A, Jayo M, Van Delden C, Lescuyer P, Pfister M, Chalandon Y, Neofytos D. Royston L, et al. Among authors: chalandon y. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0065722. doi: 10.1128/aac.00657-22. Epub 2022 Jul 25. Antimicrob Agents Chemother. 2022. PMID: 35876579 Free PMC article.
Invasive zygomycosis in transplant recipients.
Uçkay I, Chalandon Y, Sartoretti P, Rohner P, Berney T, Hadaya K, van Delden C. Uçkay I, et al. Among authors: chalandon y. Clin Transplant. 2007 Jul-Aug;21(4):577-82. doi: 10.1111/j.1399-0012.2007.00684.x. Clin Transplant. 2007. PMID: 17645724
Invasive microsporidiosis in allogeneic haematopoietic SCT recipients.
Ambrosioni J, van Delden C, Krause KH, Bouchuiguir-Wafa C, Nagy M, Passweg J, Chalandon Y. Ambrosioni J, et al. Among authors: chalandon y. Bone Marrow Transplant. 2010 Jul;45(7):1249-51. doi: 10.1038/bmt.2009.315. Epub 2009 Nov 16. Bone Marrow Transplant. 2010. PMID: 19915628 No abstract available.
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.
Mohty B, Bel M, Vukicevic M, Nagy M, Levrat E, Meier S, Grillet S, Combescure C, Kaiser L, Chalandon Y, Passweg J, Siegrist CA, Roosnek E; Blood and Marrow Transplant Program; Geneva University Hospitals H1N1 study group. Mohty B, et al. Among authors: chalandon y. Haematologica. 2011 Jun;96(6):896-904. doi: 10.3324/haematol.2011.040386. Epub 2011 Mar 21. Haematologica. 2011. PMID: 21422117 Free PMC article. Clinical Trial.
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion.
Beauverd Y, Roosnek E, Tirefort Y, Nagy-Hulliger M, Bernimoulin M, Tsopra O, Ansari M, Dantin C, Casini A, Grandjean AP, Chigrinova E, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: chalandon y. Biol Blood Marrow Transplant. 2014 Sep;20(9):1322-8. doi: 10.1016/j.bbmt.2014.04.023. Epub 2014 Apr 24. Biol Blood Marrow Transplant. 2014. PMID: 24769318 Free article.
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.
Gotta V, Widmer N, Decosterd LA, Chalandon Y, Heim D, Gregor M, Benz R, Leoncini-Franscini L, Baerlocher GM, Duchosal MA, Csajka C, Buclin T. Gotta V, et al. Among authors: chalandon y. Cancer Chemother Pharmacol. 2014 Dec;74(6):1307-19. doi: 10.1007/s00280-014-2599-1. Epub 2014 Oct 9. Cancer Chemother Pharmacol. 2014. PMID: 25297989 Free article. Clinical Trial.
315 results